Reaxbio
2 known investors
ReAx is a chemoproteomics drug discovery company using its discovery platform to develop first-in-class and best-in-class therapies for challenging protein targets. The company brings together expertise in biology, chemistry, and computation.
Investors · 2
Frequently asked questions
- What does Reaxbio do?
- ReAx is a chemoproteomics drug discovery company using its discovery platform to develop first-in-class and best-in-class therapies for challenging protein targets. The company brings together expertise in biology, chemistry, and computation.
- Who are Reaxbio's investors?
- Reaxbio's investors include OMX Ventures, Portal Innovations.